[Role of natriuretic peptides in blood pressure regulation].
Hirata
Yasunobu
Y
Department of Cardiovascular Medicine, University of Tokyo.
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D009320:Atrial Natriuretic Factor / Q000627:therapeutic use; D001794:Blood Pressure; D006152:Cyclic GMP / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism; D009318:Natriuresis; D045265:Natriuretic Peptides / Q000097:blood / Q000378:metabolism / Q000502:physiology*; D015260:Neprilysin / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use; D014664:Vasodilation
D000959:Antihypertensive Agents; D045265:Natriuretic Peptides; D011480:Protease Inhibitors; D011725:Pyridines; D011994:Recombinant Proteins; D013841:Thiazepines; C106266:omapatrilat; D009320:Atrial Natriuretic Factor; D015260:Neprilysin; D006152:Cyclic GMP